Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: the Chief who wrote (1578)	4/3/1999 8:21:00 AM
From: Jeff Chan	Read Replies (1) of 14101

Ah...now I remember SYN (Synsorb Biotech)... Apologies for being off topic. SYN is engaged in three major areas. 1. Agent to fight e. coli (hamburger disease)...not a huge market, but who knows? 2. Antibiotic induced diarrhea...as stated in their website...metronidazole is the agent of first choice and it is CHEAP, CHEAP, CHEAP...however, there is a 10-20% failure rate, but then the second drug of choice is oral vancomycin (which is much more expensive), but probably still cheaper than SYN's product. 3. Cancer...seems like everyone's investigating a novel way of fighting cancer these days. Regards, JEff

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next